Skip to content

Industry
- Residential
- Office
- Retail
- Industrial
- Hospitality
- Land
- Healthcare
- Life Sciences
- Special Purpose
- Mixed-Use
Markets
- Los Angeles
- New York City
- Manhattan
- Queens
- Bronx
- National
- Washington DC
- South Florida
Leases
Finance
Investments
Development
Capital Markets
Tech
Weekly Issue
Events
Power
More

Sign In Sign Up My Account Sign Out

Account Details
Email Preferences
Member FAQs
Sign Out

Industry
Residential
Office
- Coworking
- Flex
Retail
Industrial
Hospitality
Land
- Farm Land
- Parking Lots
Healthcare
Life Sciences
Special Purpose
Infrastructure
Mixed-Use
Markets
- Los Angeles
- New York City
- Manhattan
- Queens
- Bronx
- National
- Washington DC
- South Florida
Leases
Finance
Investments & Sales
Development
Capital Markets
Technology
Policy
Legal
Weekly Issue
Events
Power Series
More
Advertise
Contact
Reprints
Newsletters

Power Finance
Power 100
Owners Magazine

Sign In Sign Up My Account Sign Out

Account Details
Email Preferences
Member FAQs
Sign Out

© 2026 Observer Media · Terms · Privacy

John Rim

Samsung Biologics CEO John Rim and two of Human Genome Science's manufacturing sites in Rockville, Md.

Life Sciences · Investments & Sales

Samsung Biologics to Acquire First U.S. Drug Manufacturing Facility in $280M Deal

By Nick Trombola

All posts loaded.

Industry
Leases
Finance
Investments
Development
Capital Markets
Technology
More
About
- Membership
- Advertise
- Newsletters
- Contact
- Reprints

Read the latest edition of the Commercial Observer online!

© 2026 Observer Media Terms Privacy Cookie Settings Do not sell my data Sitemap